Formidable Asset Management, LLC Cytom X Therapeutics, Inc. Transaction History
Formidable Asset Management, LLC
- $574 Million
- Q1 2025
A detailed history of Formidable Asset Management, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Formidable Asset Management, LLC holds 353,840 shares of CTMX stock, worth $332,609. This represents 0.04% of its overall portfolio holdings.
Number of Shares
353,840
Previous 382,529
7.5%
Holding current value
$332,609
Previous $394,000
42.64%
% of portfolio
0.04%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding CTMX
# of Institutions
70Shares Held
46.7MCall Options Held
3.7KPut Options Held
4.7K-
Tang Capital Management LLC San Diego, CA7.31MShares$6.87 Million0.57% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$4.91 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.16MShares$4.85 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.91MShares$3.67 Million1.19% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.22MShares$3.03 Million0.0% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $62M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...